10 January 2025
Tern Plc
("Tern" or the "Company")
Investor Presentations
Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, is pleased to announce that following a well-attended online presentation and a Q&A session yesterday evening involving Tern's portfolio companies Device Authority, FundamentalVR, Talking Medicines and Vortex IQ (a Sure Valley Enterprise Capital Fund (SVV2) portfolio company), copies of the presentations from the participating companies can be found via the links below:
Device Authority presentation: http://www.rns-pdf.londonstockexchange.com/rns/8270S_1-2025-1-9.pdf
FundamentalVR presentation: http://www.rns-pdf.londonstockexchange.com/rns/8270S_2-2025-1-9.pdf
Talking Medicines presentation: http://www.rns-pdf.londonstockexchange.com/rns/8270S_3-2025-1-9.pdf
Vortex IQ presentation: http://www.rns-pdf.londonstockexchange.com/rns/8270S_4-2025-1-9.pdf
In addition a recording of the event is available to view on the Company's website at: https://www.ternplc.com/resources
Enquiries
| Tern Plc Ian Ritchie (Chairman) | via IFC Advisory |
|
Allenby Capital Limited (Nominated Adviser and Broker) Alex Brearley / Dan Dearden-Williams (Corporate Finance) Kelly Gardiner / Guy McDougall (Sales and Corporate Broking) |
Tel: 0203 328 5656 |
|
IFC Advisory (Financial PR and IR) Tim Metcalfe Graham Herring Florence Chandler |
Tel: 0203 934 6630 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
